Home » Topics » Drug design, drug delivery and technologies, BioWorld Science

Drug design, drug delivery and technologies, BioWorld Science
RSS

Xenova and Warner-Lambert extend NatChem drug discovery collaboration

Oct. 19, 1998

No Comments

Genset, Pharmacia & Upjohn collaborate in pharmacogenomics research

Oct. 14, 1998

No Comments

Myriad Genetics, Schering AG collaborate on new drug development

Oct. 9, 1998

No Comments

ThromboSol effectively preserves platelet function and cell recovery in in vivo study

Oct. 8, 1998

No Comments

Centocor exercises option for license to HuMAb-Mouse technology

Oct. 6, 1998

No Comments

Aurora Biosciences completes first stage of UHTSS for Warner-Lambert

Oct. 6, 1998

No Comments

Merck KGaA, 3DP extend drug discovery agreement for another year

Oct. 5, 1998

No Comments

Bayer, Millennium form the largest drug discovery alliance in history

Sep. 29, 1998

No Comments

Tranzyme obtains technology license from U. of Alabama

Sep. 24, 1998

No Comments

PowderJect delivery of DNA vaccines validated in preclinical study

Sep. 24, 1998

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Drug design, drug delivery and technologies, BioWorld Science
RSS

Xenova and Warner-Lambert extend NatChem drug discovery collaboration

Genset, Pharmacia & Upjohn collaborate in pharmacogenomics research

Myriad Genetics, Schering AG collaborate on new drug development

ThromboSol effectively preserves platelet function and cell recovery in in vivo study

Centocor exercises option for license to HuMAb-Mouse technology

Aurora Biosciences completes first stage of UHTSS for Warner-Lambert

Merck KGaA, 3DP extend drug discovery agreement for another year

Bayer, Millennium form the largest drug discovery alliance in history

Tranzyme obtains technology license from U. of Alabama

PowderJect delivery of DNA vaccines validated in preclinical study

Today's news in brief

Today's news in brief

Caplyta star shines as J&J takes Intra-Cellular in $14.6B deal

Proteomics study explores how protein changes influence disease

Abbvie and Simcere enter a $1B T-cell engager deal

Drug design, drug delivery and technologies, BioWorld Science RSS

Drug design, drug delivery and technologies, BioWorld Science
RSS